It will be part of a multi-country, multidisciplinary study that is agreed by the World Health Organization (WHO)
His first test of drugs for the Ebola treatment was announced by the Ministry of Health of the Democratic Republic. Congo (DRC). This oversight test has begun to evaluate the effectiveness and safety of drugs involved; used in the treatment of Ebola patients.
It will be part of a multi-lingual multi-country study that is agreed by World Health Organization (WHO) partners.
Professor Tedros Adhanom Ghebreyesus, Chief Executive of WHO, said: "Although our focus is still on completion of this case, it has a control lawsuit randomly in the DRC is an important step in recovering Ebola's ultimate remedy to save life. To date, patients are treated under poor drug protocol, with drugs that showed a commitment and had a good safety in The occupational situations. The DRC's major step will now provide clarity on what works best, and save a lot of life in the years ahead. We hope one day says that Ebola's death and suffering are behind him. "
The current test is coordinated by WHO, led and sponsored by the DRC National Institute for Biological Research (INRB), in partnership with the DRC Health Ministry, National Institute of Art Gallery and Infectious Diseases (NIAID) that is part of the United Nations United Nations National Institute of Health, The Alliance for International Action Action (ALIMA) and other organizations.
To date, more than 160 patients with treatment remedies have been dealt with under the ethical framework developed by WHO, in consultation with field experts and the DRC, known as the Interpretation of Emergency Practice on Inter- Unregistered and Investigations (MEURI).
The MEURI protocol has not been designed to evaluate the drugs. Now the protocols for tested tests, patients will be offered caresuits under that framework in the facilities where the test starts. In others, the use of pollution will continue up to the time they come into the disaster. Patients will not be treated differently from before, although the cure they receive will be determined by random allocation.
The data collected will be met and it will be useful to make decisions on the safety and effectiveness of drugs.
Dr Olly Ilunga, DRC's Health Minister, said, "Our country has often been hit by ewee, which also has a great experience in fighting These tests will add to the construction of that knowledge, as long as we continue to respond to each other to determine the situation; at the end of the moment. "
WHO held a meeting of international organizations, United Nations partners, countries that are at risk of Ebola, drug makers and others to agree on a framework for holding exams in the next Ebola tour in the month of October.
Over time, this will generate a gathering of evidence that helps to draw strong decisions over the drugs currently available, and new ones that may come.